Biblio

Export 244 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Keyword is I  [Clear All Filters]
2018
A. Synn, Mothakunnel, A., Kumfor, F., Chen, Y., Piguet, O., Hodges, J. R., and Irish, M., “Mental States in Moving Shapes: Distinct Cortical and Subcortical Contributions to Theory of Mind Impairments in Dementia.”, J Alzheimers Dis, vol. 61, no. 2, pp. 521-535, 2018.
M. El Haj, Coello, Y., Kapogiannis, D., Gallouj, K., and Antoine, P., “Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".”, J Alzheimers Dis, vol. 61, no. 2, pp. 663-672, 2018.
M. L. Croze and Zimmer, L., “Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.”, J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
M. L. Croze and Zimmer, L., “Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.”, J Alzheimers Dis, vol. 62, no. 2, pp. 503-522, 2018.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
Q. Tao, Zhu, H., Chen, X., Stern, R. A., Kowall, N., Au, R., Blusztajn, J. Krzysztof, and Qiu, W. Qiao, “Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
C. Lange, Suppa, P., Pietrzyk, U., Makowski, M. R., Spies, L., Peters, O., and Buchert, R., “Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.”, J Alzheimers Dis, vol. 61, no. 1, pp. 373-388, 2018.
M. R. Redston, Hilmer, S. N., McLachlan, A. J., Clough, A. J., and Gnjidic, D., “Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1639-1652, 2018.
M. Serpente, Fenoglio, C., Cioffi, S. Maria Giul, Oldoni, E., Arcaro, M., Arighi, A., Fumagalli, G. Giulio, Ghezzi, L., Scarpini, E., and Galimberti, D., “Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1289-1294, 2018.
C. Kaindlstorfer, Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiss, G., and Wenning, G. K., “The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1253-1273, 2018.
C. Kaindlstorfer, Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiss, G., and Wenning, G. K., “The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1253-1273, 2018.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., “SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
T. Nikolai, Stepankova, H., Kopecek, M., Sulc, Z., Vyhnálek, M., and Bezdicek, O., “The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
T. van Middelaar, van Dalen, J. W., van Gool, W. A., van den Born, B. - J. H., van Vught, L. A., van Charante, E. P. Moll, and Richard, E., “Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People.”, J Alzheimers Dis, vol. 62, no. 2, pp. 727-735, 2018.
D. Ding, Xiong, Y., Zhao, Q., Guo, Q., Chu, S., Chu, W. W. C., Luo, J., Liang, X., Zheng, L., Hong, Z., Wong, L. K. S., and Mok, V. C. T., “White Matter Hyperintensity Predicts the Risk of Incident Cognitive Decline in Community Dwelling Elderly.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1333-1341, 2018.
A. Arighi, Carandini, T., Mercurio, M., Carpani, G., Pietroboni, A. Margherita, Fumagalli, G., Ghezzi, L., Basilico, P., Calvi, A., Scarioni, M., De Riz, M., Fenoglio, C., Scola, E., Triulzi, F., Galimberti, D., and Scarpini, E., “Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?”, J Alzheimers Dis, vol. 61, no. 1, pp. 47-52, 2018.
2020
V. Yamamoto, Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., Sokolov, R., Wheeler, C., Kaushik, A., Elsayegh, A., Eliashiv, D., Hedrick, R., Jafari, B., J Johnson, P., Khorsandi, M., Gonzalez, N., Balakhani, G., Lahiri, S., Ghavidel, K., Amaya, M., Kloor, H., Hussain, N., Huang, E., Cormier, J., J Ashford, W., Wang, J. C., Yaghobian, S., Khorrami, P., Shamloo, B., Moon, C., Shadi, P., and Kateb, B., “COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.”, J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
M. Fotuhi, Mian, A., Meysami, S., and Raji, C. A., “Neurobiology of COVID-19.”, J Alzheimers Dis, vol. 76, no. 1, pp. 3-19, 2020.
S. X. Naughton, Raval, U., and Pasinetti, G. M., “Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.”, J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
R. Capozzo, Zoccolella, S., Frisullo, M. Elisa, Barone, R., Dell'Abate, M. Teresa, Barulli, M. Rosaria, Musio, M., Accogli, M., and Logroscino, G., “Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.”, J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
2021
A. Lladó, Froelich, L., Khandker, R. K., Roset, M., Black, C. M., Lara, N., Chekani, F., and Ambegaonkar, B. M., “Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.”, J Alzheimers Dis, vol. 80, no. 2, pp. 749-759, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P., “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., “Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., “Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.

Pages